Paul Schimmel, Director at aTYR PHARMA INC (LIFE), bought 239,547 shares at $0.72 ($176K) on 2018-08-29, disclosed to the SEC on 2018-08-31.
Open-market purchase of $176k LIFE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.72 | 75,136 | $54K | 30.7% |
| 2 | $0.72 | 75,136 | $54K | 30.7% |
| 3 | $0.76 | 89,275 | $68K | 38.5% |
| Total | $0.73 avg | 239,547 | $176K | 100% |
| Filing → |
| ATYR | BUY | 2024-07-24 | $256K | — | Filing → |
| LIFE | BUY | 2023-05-11 | $450K | — | Filing → |
| LIFE | BUY | 2021-09-22 | $2.0M | — | Filing → |